Biotech Medics Ne Stock Buy Hold or Sell Recommendation
| BMCS Stock | USD 0.01 0.01 64.71% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Biotech Medics Ne is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Biotech Medics Ne given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Biotech Medics Ne, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Biotech Medics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Biotech and provide practical buy, sell, or hold advice based on investors' constraints. Biotech Medics Ne. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Biotech |
Execute Biotech Medics Buy or Sell Advice
The Biotech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biotech Medics Ne. Macroaxis does not own or have any residual interests in Biotech Medics Ne or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biotech Medics' advice using the current market data and latest reported fundamentals.
Time Horizon
3 Months |
Risk Tolerance
I am an educated risk taker |
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Biotech Medics Trading Alerts and Improvement Suggestions
| Biotech Medics Ne had very high historical volatility over the last 90 days | |
| Biotech Medics Ne has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biotech Medics until it has trouble settling it off, either with new capital or with free cash flow. So, Biotech Medics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotech Medics Ne sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotech to invest in growth at high rates of return. When we think about Biotech Medics' use of debt, we should always consider it together with cash and equity. | |
| Biotech Medics Ne reported the previous year's revenue of 469.8 K. Net Loss for the year was (603.72 K) with profit before overhead, payroll, taxes, and interest of 408.14 K. |
Biotech Medics Returns Distribution Density
The distribution of Biotech Medics' historical returns is an attempt to chart the uncertainty of Biotech Medics' future price movements. The chart of the probability distribution of Biotech Medics daily returns describes the distribution of returns around its average expected value. We use Biotech Medics Ne price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biotech Medics returns is essential to provide solid investment advice for Biotech Medics.
| Mean Return | 0.41 |
| Value At Risk | -14.29 |
| Potential Upside | 13.57 |
| Standard Deviation | 10.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biotech Medics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biotech Medics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biotech Medics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biotech Medics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biotech pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | -1.13 | |
σ | Overall volatility | 10.00 | |
Ir | Information ratio | 0.04 |
Biotech Medics Volatility Alert
Biotech Medics Ne is showing large volatility of returns over the selected time horizon. Biotech Medics Ne is a penny stock. Although Biotech Medics may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Biotech Medics Ne. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Biotech instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Biotech Medics Fundamentals Vs Peers
Comparing Biotech Medics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biotech Medics' direct or indirect competition across all of the common fundamentals between Biotech Medics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biotech Medics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Biotech Medics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biotech Medics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biotech Medics to competition |
| Fundamentals | Biotech Medics | Peer Average |
| Profit Margin | (1.29) % | (1.27) % |
| Operating Margin | (1.24) % | (5.51) % |
| Current Valuation | 9.68 M | 16.62 B |
| Shares Outstanding | 172.36 M | 571.82 M |
| Price To Earning | (0.47) X | 28.72 X |
| Price To Sales | 3.30 X | 11.42 X |
| Revenue | 469.8 K | 9.43 B |
| Gross Profit | 408.14 K | 27.38 B |
| EBITDA | 33.35 K | 3.9 B |
| Net Income | (603.72 K) | 570.98 M |
| Cash And Equivalents | 1.31 K | 2.7 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 0.01 X | 2.16 X |
| Book Value Per Share | 0.02 X | 1.93 K |
| Earnings Per Share | (0) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 3.5 | -0.15 |
| Market Capitalization | 870.4 K | 19.03 B |
| Total Asset | 5.08 M | 29.47 B |
| Retained Earnings | (1.75 M) | 9.33 B |
| Working Capital | (1.98 M) | 1.48 B |
| Current Asset | 27 K | 9.34 B |
| Current Liabilities | 2.01 M | 7.9 B |
| Net Asset | 5.08 M |
Biotech Medics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biotech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biotech Medics Buy or Sell Advice
When is the right time to buy or sell Biotech Medics Ne? Buying financial instruments such as Biotech Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biotech Medics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Candy and Soda Thematic Idea Now
Candy and Soda
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Candy and Soda theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Candy and Soda Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.